Predicting and monitoring treatment response via 1-H NMR metabolomics of plasma, serum, and urine

Key Points

• Treatment response prediction is enhanced by using 1-H NMR metabolomics data from plasma, serum, and urine.
• Key indicators reveal significant changes in metabolites associated with treatment response.
• Observational analysis across multiple body fluids uncovers distinct biomarker patterns linked to treatment effectiveness.
• Highlights the potential use of non-invasive metabolomic profiling for therapeutic monitoring and optimizing treatment.